1. European Medicines Agency . 2012. Remicade: summary of product characteristics, European Public Assessment Report Product Information WC500050888. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000240/WC500050883.pdf .
2. European Medicines Agency . 2004. Humira scientific discussion, European Public Assessment Report Scientific Discussion WC500050867. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000481/WC500050867.pdf .
3. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
4. Immunogenicity of biologic agents in rheumatoid arthritis patients: lessons for clinical practice
5. Immunogenicity of mAbs in non-human primates during nonclinical safety assessment